560 related articles for article (PubMed ID: 34156126)
1. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
[TBL] [Abstract][Full Text] [Related]
2. Advances in genetic mechanisms of hypothalamic dysfunction in Prader-Willi syndrome.
Wang XY; Sun R; Gao YQ
Yi Chuan; 2022 Oct; 44(10):899-912. PubMed ID: 36384726
[TBL] [Abstract][Full Text] [Related]
3. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.
Muscogiuri G; Formoso G; Pugliese G; Ruggeri RM; Scarano E; Colao A;
Rev Endocr Metab Disord; 2019 Jun; 20(2):239-250. PubMed ID: 31065942
[TBL] [Abstract][Full Text] [Related]
4. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
[TBL] [Abstract][Full Text] [Related]
5. Prader-Willi syndrome: an update on obesity and endocrine problems.
Kim SJ; Cho SY; Jin DK
Ann Pediatr Endocrinol Metab; 2021 Dec; 26(4):227-236. PubMed ID: 34991300
[TBL] [Abstract][Full Text] [Related]
6. Changeability of the fully methylated status of the 15q11.2 region in induced pluripotent stem cells derived from a patient with Prader-Willi syndrome.
Okuno H; Nakabayashi K; Abe K; Ando T; Sanosaka T; Kohyama J; Akamatsu W; Ohyama M; Takahashi T; Kosaki K; Okano H
Congenit Anom (Kyoto); 2017 Jul; 57(4):96-103. PubMed ID: 28004416
[TBL] [Abstract][Full Text] [Related]
7. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
Griggs JL; Sinnayah P; Mathai ML
Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
[TBL] [Abstract][Full Text] [Related]
8. Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader-Willi syndrome.
Davies JR; Humby T; Dwyer DM; Garfield AS; Furby H; Wilkinson LS; Wells T; Isles AR
Eur J Neurosci; 2015 Aug; 42(4):2105-13. PubMed ID: 26040449
[TBL] [Abstract][Full Text] [Related]
9. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
10. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
Angulo MA; Butler MG; Cataletto ME
J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of obesity in Prader-Willi syndrome.
Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
[TBL] [Abstract][Full Text] [Related]
12. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
13. Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review.
Napolitano L; Barone B; Morra S; Celentano G; La Rocca R; Capece M; Morgera V; Turco C; Caputo VF; Spena G; Romano L; De Luca L; Califano G; Collà Ruvolo C; Mangiapia F; Mirone V; Longo N; Creta M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671467
[TBL] [Abstract][Full Text] [Related]
14. Prader-Willi syndrome: endocrine manifestations and management.
Alves C; Franco RR
Arch Endocrinol Metab; 2020; 64(3):223-234. PubMed ID: 32555988
[TBL] [Abstract][Full Text] [Related]
15. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.
Burnett LC; LeDuc CA; Sulsona CR; Paull D; Rausch R; Eddiry S; Carli JF; Morabito MV; Skowronski AA; Hubner G; Zimmer M; Wang L; Day R; Levy B; Fennoy I; Dubern B; Poitou C; Clement K; Butler MG; Rosenbaum M; Salles JP; Tauber M; Driscoll DJ; Egli D; Leibel RL
J Clin Invest; 2017 Jan; 127(1):293-305. PubMed ID: 27941249
[TBL] [Abstract][Full Text] [Related]
17. Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.
Oztan O; Zyga O; Stafford DEJ; Parker KJ
Neurosci Biobehav Rev; 2022 Nov; 142():104870. PubMed ID: 36113782
[TBL] [Abstract][Full Text] [Related]
18. The hypothalamus, hormones, and hunger: alterations in human obesity and illness.
Goldstone AP
Prog Brain Res; 2006; 153():57-73. PubMed ID: 16876568
[TBL] [Abstract][Full Text] [Related]
19. A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome.
Bochukova EG; Lawler K; Croizier S; Keogh JM; Patel N; Strohbehn G; Lo KK; Humphrey J; Hokken-Koelega A; Damen L; Donze S; Bouret SG; Plagnol V; Farooqi IS
Cell Rep; 2018 Mar; 22(13):3401-3408. PubMed ID: 29590610
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome.
Polex-Wolf J; Lam BY; Larder R; Tadross J; Rimmington D; Bosch F; Cenzano VJ; Ayuso E; Ma MK; Rainbow K; Coll AP; O'Rahilly S; Yeo GS
J Clin Invest; 2018 Mar; 128(3):960-969. PubMed ID: 29376887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
